Genetic testing refers to the methodical diagnostic and screening techniques used to detect the possibility of genetic anomalies in unicellular and multicellular organisms. In particular, prenatal and newborn genetic testing refers to employing screening/diagnostic procedures to detect chromosomal abnormalities such as Patau syndrome, Edward syndrome, and Down syndrome in a fetus or a newborn. The technique comprises biochemical tests in order to identify the possible presence of genetic disorders or mutated genes that have higher risk of developing into genetic disorders later.
Sample Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744
Detection of Genetic Abnormalities at Early Stage of Gestation Propels Market
Worldwide, some of the factors driving the global prenatal and newborn genetic testing market are late childbearing due to changing lifestyles, technological advancements leading to the development of accurate testing mechanisms, and rising awareness regarding the detection of fetal abnormalities.
Due to the increasing number of chromosomal defects among fetuses, a rising number of expectant mothers are undergoing screening procedures in order to detect genetic abnormalities at an early stage. Prenatal testing identifies genetic abnormalities as early as 8 to 10 weeks of gestation for timely action to be taken jointly by the caregiver and the expectant couple.
According to data from the Northwestern Medical Faculty Foundation, in the U.S., the majority of pregnant women undergo screening or testing for the detection of birth defects such as trisomy 18, Down syndrome, and open neural tube defects.
However, lack of education and presence of faith-based notions have been the reasons for misuse of prenatal genetic testing to determine the sex of the fetus in some parts of the world. For such reasons, strict mandates have been put in place by several governments for prenatal testing procedures carried out for personal gain.
Hence, owing to the large economic and social benefit of these procedure, the global prenatal and newborn testing market is expected to display an impressive 26.9% CAGR from 2013 to 2019 and reach a valuation of US$8.3 bn by 2019. The market, which stood at US$1.1 bn in 2012, is expected to be worth US$8.3 bn by 2019.
Polymerase Chain Reaction (PCR) Dominates Global Market
The global market for prenatal and newborn testing is divided on the basis of technology and geography. By technology, the market is segmented into screening methods and diagnostic techniques. The diagnostic technology segment is sub-segmented into fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), and array-comparative genomic hybridization (aCGH).
Amongst all, PCR accounts for the largest share of the global market for prenatal and newborn testing, followed by aCGH and FISH. The large market share of this segment is attributed to the increasing incidence of genetic diseases, combined with favorable features of PCR such as high accuracy and reliability, and procedural efficiency.
Negligible Miscarriage Risk Leads to Increasing Use of NIPT Worldwide
The screening technology segment of the overall market is sub-segmented into maternal serum screening (MSS) and noninvasive prenatal tests (Verifi, NIFTY, Bambini Test, MaterniT21 Plus, Harmony, and PrenaTest).
Noninvasive prenatal testing (NIPT) is currently the largest market segment. It is expected to exhibit the highest CAGR of 37.60% from 2013 to 2019.By geography, the global market for prenatal and newborn genetic testing is divided into four regions, namely North America, Asia Pacific, Europe, and Rest of the World (RoW).
North America stands as the largest market for prenatal and newborn genetic testing owing to the increasing popularity of NIPT in this region. Being noninvasive and carrying negligible chances of miscarriage, NIPT is the most sought-after screening technique in the region.
Browse Full Global Prenatal and Newborn Genetic Testing Market Report With Complete TOC @ http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.